KEROS THERAPEUTICS INCKROS

Neutral

ASignal's systematic analysis rates KROS as Neutral.

Reflects the latest available analysis · analyzed Oct 15, 2026

The case on KROS

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong cash position with $257.61M in total cash
  • Low debt-to-equity ratio of 0.06x indicating minimal leverage risk
  • High current and quick ratios (21.96x and 21.47x) signaling strong short-term liquidity
  • Price near Bollinger Lower Band (10.93) suggesting potential mean reversion
VS
Bear case
  • Negative MACD histogram and MACD below signal line indicating weakening momentum
  • Negative price momentum (-0.0187) and RSI near neutral but trending down
  • Extremely high operating margin of -655.84% reflecting severe cost inefficiencies
  • Negative return on equity (-17.16%) and return on assets (-11.78%)
  • Negative enterprise value (-$22.79M) and negative free cash flow (-$27.17M)
  • No recent news coverage or Reddit mentions indicating low market sentiment
Subscriber-only

See the full verdict on KROS

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes KROS

Most investors never get a second opinion, let alone several. ASignal runs KROS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

KEROS THERAPEUTICS INC (KROS) Stock Analysis - ASignal rates it Neutral